Erratum to: Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment (Metabolomics, 2016, 12, (58), 10.1007/s11306-016-0961-5);Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment

Metabolomics

Volumn 12, Issue 3, 2016, Pages 1-9

  Hao, Desirée ^a   Sarfaraz, M Omair ^a,b   Farshidfar, Farshad ^c   Bebb, D Gwyn ^a   Lee, Camelia Y ^d   Card, Cynthia M ^a   David, Marilyn ^d   Weljie, Aalim M ^a,e,f  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d TOM BAKER CANCER CENTRE   (Canada)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

GC MS; Lung cancer; Metabolomics; NMR; Personalized medicine; Pharmacometabolomics

Indexed keywords

EID: 84959344007     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-016-1068-8     Document Type: Erratum

References (33)

1. Bathe, O. F., et al. (2011). Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidemiology, Biomarkers and Prevention,20(1), 140–147.
2. Boros, L.G. & Somlyai, G. (2015). Compartmentalized NADPH Synthesis, Intramolecular Deuterium Disequilibrium and Water Pools of Mammalian Cells.
3. Boros, L. G., et al. (2014). Abstract 1426: Fumarate hydratase and deuterium depletion control oncogenesis via NADPH-dependent reductive synthesis: mitochondrial matrix water, DNA deuteration and epigenetic events. Cancer Research,74(19 Supplement), 1426.
4. Carrola, J., et al. (2011). Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. Journal of Proteome Research,10(1), 221–230.
5. Chen, Y., et al. (2009). RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: Finding potential biomarkers for breast cancer. Analyst,134(10), 2003–2011.
6. Cong, F. S. (2010). Deuterium-depleted water inhibits human lung carcinoma cell growth by apoptosis. Experimental and Therapeutic Medicine,1(2), 277–283.
7. Deja, S., et al. (2014). Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease. Journal of Pharmaceutical and Biomedical Analysis,100C, 369–380.
8. Denery, J. R., Nunes, A. A. K., & Dickerson, T. J. (2011). Characterization of differences between blood sample matrices in untargeted metabolomics. Analytical Chemistry,83(3), 1040–1047.
9. Duan, J.-R., et al. (2002). Natural deuterium distribution in fatty acids isolated from peanut seed oil: A site-specific study by quantitative 2H NMR spectroscopy. ChemBioChem,3(8), 752.
10. Fan, T. W., et al. (2009). Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM). Molecular Cancer,8(1), 41.
11. Farshidfar, F., et al. (2012). Serum metabolomic profile as a means to distinguish stage of colorectal cancer. Genome medicine,4(5), 42.
12. Gu, H., et al. (2011). Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: Application to the detection of breast cancer. Analytica Chimica Acta,686(1–2), 57–63.
13. Hiller, K., et al. (2009). MetaboliteDetector: Comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis. Analytical Chemistry,81(9), 3429–3439.
14. Hori, S., et al. (2011). A metabolomic approach to lung cancer. Lung Cancer (Amsterdam, Netherlands),74(2), 284–292.
15. Jordan, K. W., et al. (2010). Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue–serum pairs. Lung Cancer (Amsterdam, Netherlands),68(1), 44–50.
16. Liu, L., et al. (2010). Differences in metabolite profile between blood plasma and serum. Analytical Biochemistry,406(2), 105–112.
17. Lokhov, P. G., et al. (2013). Blood plasma metabolites and the risk of developing lung cancer in Russia. European Journal of Cancer Prevention,22(4), 335–341.
18. Morvan, D., & Demidem, A. (2007). Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. Cancer Research,67(5), 2150–2159.
19. Odunsi, K., et al. (2005). Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. International Journal of Cancer,113(5), 782–788.
20. Psihogios, N. G., et al. (2007). Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR in Biomedicine,21(3), 195–207.
21. Rocha, C. M., et al. (2011). Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma. Journal of Proteome Research,10(9), 4314–4324.
22. Sawyers, C. L. (2008). The cancer biomarker problem. Nature,452(7187), 548–552.
23. Schmidt, H. L., Werner, R. A., & Eisenreich, W. (2003). Systematics of 2H patterns in natural compounds and its importance for the elucidation of biosynthetic pathways. Phytochemistry Reviews,2, 61–85.
24. Sobczyk, L., Obrzud, M., & Filarowski, A. (2013). H/D isotope effects in hydrogen bonded systems. Molecules,18(4), 4467–4476.
25. Sreekumar, A., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature,457(7231), 910–914.
26. Wedge, D. C., et al. (2011). Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer. Analytical Chemistry,83(17), 6689–6697.
27. Weljie, A. M., et al. (2006). Targeted profiling: Quantitative analysis of 1H NMR metabolomics data. Analytical Chemistry,78(13), 4430–4442.
28. Weljie, A. M., et al. (2007). An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy. Journal of Proteome Research,6(9), 3456–3464.
29. Wen, T., et al. (2013). Exploratory investigation of plasma metabolomics in human lung adenocarcinoma. Molecular BioSystems,9(9), 2370–2378.
30. Yang, Q., et al. (2010). Urinary metabonomic study of lung cancer by a fully automatic hyphenated hydrophilic interaction/RPLC-MS system. Journal of Separation Science,33(10), 1495–1503.
31. Yu, Z., et al. (2011). Differences between human plasma and serum metabolite profiles. PLoS One,6(7), e21230.
32. Zhang, S. (2007). A comprehensive evaluation of SAM, the SAM R-package and a simple modification to improve its performance. BMC Bioinformatics,8(1), 230.
33. Zhang, J., et al. (2012). Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One,7(1), e30181.